SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is trending as investors react to the Vineland planning board's approval of its data center project, fueling intense debate between bulls expecting a short squeeze toward $300 and bears questioning the stock's valuation. Community discussions are heavily focused on the clash between institutional momentum and high-profile short sellers, with many debating whether the regulatory de-risking event justifies the current market premium.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is currently drawing intense interest as institutional backing grows, highlighted by major firms like Morgan Stanley, Vanguard, and UBS significantly increasing their positions during the last quarter. While community sentiment remains polarized, ongoing discussions center on the company's expanding government contracts, the strategic importance of its recent FCC approvals, and the race to solidify launch schedules amidst a high-stakes competitive landscape.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is experiencing a significant sell-off to multi-year lows, driven by investor anxiety over weakened revenue, stiffening competition in the athletic footwear sector, and internal leadership uncertainty. While some in the community view the current price as a generational buying opportunity and a potential value play given the dividend yield, many others remain bearish, citing poor brand relevance, high inventory concerns, and ongoing debates over management's strategic direction.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Market sentiment remains divided as traders weigh the impact of rising 30-year Treasury yields against persistent geopolitical instability in the Strait of Hormuz. While some investors are aggressively hedging with put options, others view the current price consolidation as a potential buying opportunity for a continued trend.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is facing heightened market volatility driven by rising Treasury yields and geopolitical uncertainty in the Strait of Hormuz, causing a split in community sentiment between those betting on an AI-driven breakout and those bracing for a potential correction. Traders are actively debating the sustainability of current valuations as bond yields reach multi-year highs, leading to significant volume in hedging activity and put option flow.

Investment Managers Series Trust II - Tradr 2X Short SNDK Daily ETF

Tradr 2X Short SNDK Daily ETF

The Tradr 2X Short SNDK Daily ETF ($SNDQ) is trending as traders closely monitor extreme volatility and the impact of the underlying asset's price fluctuations on the leveraged fund. The community is actively debating the risks of holding these instruments long-term, citing concerns over volatility decay, reverse stock splits, and broader uncertainty regarding the semiconductor sector.

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and décor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depot is trending ahead of its quarterly earnings release as investors scrutinize the company's ability to navigate persistent housing market headwinds and high interest rates. The community is actively debating whether the stocks recent decline has priced in these macro challenges or if a further pullback is imminent, while traders focus on the potential for volatility during the upcoming earnings announcement.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors focus on the company's clear clinical roadmap, specifically the upcoming BLA filing for its lead prostate cancer asset and the potential for a transformative breakthrough in the solid tumor oncology space. The community is actively discussing strong institutional accumulation, a de-risked balance sheet, and the expectation that the firm's localized immune-priming mechanism will attract significant interest from major pharmaceutical players.

ExxonMobil Holdings Corp. is an international energy and petrochemical company, which creates solutions that improve quality of life and meets society’s evolving needs. The company is headquartered in Spring, TX.

ExxonMobil Holdings Corp.

Exxon Mobil Corp

Exxon Mobil is facing increased regulatory scrutiny as the administration probes potential price gouging, while investors balance geopolitical risks in the Middle East with broader concerns over energy price volatility. The community remains focused on the company's long-term production capacity and capital allocation, with many weighing the impact of potential shifts in global energy policy against Exxon's resilient cash flow.

Himax Technologies, Inc. is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The company's products include display drivers, timing controllers, wafer level optics, video and display technology solutions, liquid crystal over silicon silicon, complementary metal-oxide semiconductor image sensor, and power integrated circuit. Its products used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, car navigation, virtual reality (VR) devices and many other consumer electronics devices. Himax Technologies was founded by Biing Seng Wu and Jordan Wu on June 12, 2001 and is headquartered in Tainan, Taiwan.

Himax Technologies - ADR

Himax Technologies, Inc.

Himax Technologies is experiencing significant market interest driven by its strategic role in the co-packaged optics ecosystem and its supply chain alignment with TSMCs COUPE platform for next-generation AI infrastructure. The community is actively monitoring the company's momentum in automotive and smart glass applications while closely tracking institutional holding shifts and the potential impact of major industry conferences on its long-term growth trajectory.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers

Exicure (NASDAQ:XCUR) stock rose 38.4% to $2.38 during Tuesday's after-market session. The market value of their outstanding shares is at $10.5 million.
Catheter Precision (AMEX:VTAK) stock moved upwardsread more...

Promising Biotech Stocks To Keep An Eye On - December 9th

WAVE Life Sciences, Exicure, argenex, Danaher, Senti Biosciences, Abivax, and Vertex Pharmaceuticals are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool...

Exicure Stock Soars 40% After Stem Cell Drug Helps Most Patients Hit Phase 2 Goal — Traders Call It ‘Cheap’ At Current Levels

Equity

The company's stem cell drug burixafor helped nearly 90% of patients meet the Phase 2 goal.

Exicure, Inc. Loss At -$2.44 Mln In Q3

(RTTNews) - Exicure, Inc. (XCUR) reported Loss for third quarter of -$2.44 million...

Halper Sadeh LLC Encourages Exicure, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Exicure, Inc. (NASDAQ: XCUR) breached their fiduciary duties to shareholders. If you...

Exicure Stock Soars Over 25% On Acquisition Of GPCR Therapeutics’ U.S. Unit: Retail Chatter Spikes 

GPCR USA is noted for its work in developing cutting-edge treatments, including Opdivo, a widely used autoimmune disease therapy generating about $10 billion in annual revenue.

Exicure Stock Surges On Blood Cancer Portfolio Acquisition Plans, Nasdaq Compliance: Retail Exuberant

Chicago-based Exicure said it intends to receive technology transfer for GPCR Therapeutics’ CXCR4 inhibitor, along with its related patents and intellectual property. 


Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The firm's product pipeline includes Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Redwood City, CA.

Exicure Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$1.38
Prev Close	$1.25
Open	$1.26
Dividend Yield	0.00%
50-Day Moving Average	$1.96
Beta	0.31
Avg. Volume	1.08M
PE Ratio	-1.06

52-Week High	$9.48
52-Week Low	$1.18
Market Capitalization	$7.97M
EPS (Annual)	-$0.7854
Price to Book	9.00
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info